Data / Drug companies / Phentermine hydrochloride
Phentermine hydrochloride: 26 companies and 120 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Phentermine hydrochloride is listed in the FDA National Drug Code Directory by 26 companies, with 120 products in commercial distribution. 120 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; tablet, and the newest product started marketing on June 25, 2026.
The request: Get every company that lists phentermine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 26
- Products
- 120
- Generic (ANDA) products
- 120 (100.0%)
- Application numbers
- 18
- Controlled substance schedule
- Schedule IV
- Routes
- Oral
- Brand names
- Phentermine, Lomaira
- openFDA record search
- api.fda.gov
Companies that list phentermine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 16 | capsule; tablet | Generic drugs (ANDA) | June 17, 2020 |
| Bryant Ranch Prepack | 14 | capsule; tablet | Generic drugs (ANDA) | February 15, 2024 |
| Calvin Scott & Co., Inc. | 9 | tablet; capsule | Generic drugs (ANDA) | February 15, 2024 |
| A-S Medication Solutions | 8 | capsule; tablet | Generic drugs (ANDA) | January 24, 2017 |
| Bryant Ranch Prepack | 8 | capsule; tablet | Generic drugs (ANDA) | February 15, 2024 |
| KVK-Tech, Inc. | 7 | capsule; tablet | Generic drugs (ANDA) | March 29, 2018 |
| NuCare Pharmaceuticals,Inc. | 6 | tablet; capsule | Generic drugs (ANDA) | January 24, 2017 |
| PD-Rx Pharmaceuticals, Inc. | 6 | capsule; tablet | Generic drugs (ANDA) | February 15, 2024 |
| Martek Pharmacal Co. | 5 | capsule; tablet | Generic drugs (ANDA) | June 1, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 4 | capsule; tablet | Generic drugs (ANDA) | August 12, 2013 |
| Proficient Rx LP | 4 | tablet; capsule | Generic drugs (ANDA) | January 24, 2017 |
| Sunrise Pharmaceutical, Inc. | 4 | capsule; tablet | Generic drugs (ANDA) | January 24, 2017 |
| Asclemed USA, Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | January 24, 2017 |
| Aurolife Pharma, LLC | 3 | capsule; tablet | Generic drugs (ANDA) | April 10, 2026 |
| Direct_Rx | 3 | tablet; capsule | Generic drugs (ANDA) | December 6, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | August 15, 2012 |
| Precision Dose, Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | February 15, 2024 |
| Preferred Pharmaceuticals Inc. | 3 | capsule; tablet | Generic drugs (ANDA) | July 28, 2021 |
| Proficient Rx LP | 3 | capsule; tablet | Generic drugs (ANDA) | August 7, 2012 |
| Northwind Health Company, LLC | 2 | tablet | Generic drugs (ANDA) | June 25, 2026 |
| Chartwell RX, LLC | 1 | tablet | Generic drugs (ANDA) | July 1, 1976 |
| Elite Laboratories, Inc. | 1 | tablet | Generic drugs (ANDA) | May 1, 2014 |
| Epic Pharma, LLC | 1 | capsule | Generic drugs (ANDA) | April 15, 2015 |
| Solco Healthcare US, LLC | 1 | tablet | Generic drugs (ANDA) | January 4, 2002 |
| Sun Pharmaceutical Industries, Inc. | 1 | tablet | Generic drugs (ANDA) | August 12, 2013 |
| Tagi Pharma, Inc. | 1 | tablet | Generic drugs (ANDA) | March 8, 2011 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 66 | 55% |
| Tablet | 54 | 45% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 120 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Sympathomimetic Amine Anorectic | 120 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.